BioNex Therapeutics
Dr. Priya Mehta · VP Regulatory Affairs KB v1Deal stage
— where this deal is in its journey, first contact to closeDeal snapshot
Win chance, the value at stake, and how far this deal has come.
Win chance
Weighted to $75K
Value at stake
Full value vs. risk-adjusted.
Pipeline progress
Engaged · 6d since touch
BioNex Therapeutics is in Engaged — $250K open, weighted to $75K at 30% win odds. Recommended next move: Follow up with BioNex Therapeutics.
Recommended: Follow up with BioNex Therapeutics
A quick read on this deal from your agent — where it stands and the smartest next move — so you're prepared before you call or email. The agent never reaches out on its own.
Deal value
$250K
The full amount if it closes.
Weighted
$75K
30% chance of closing
Owner
Suren DheenWho's running this deal — that's you.
Last activity
Your most recent logged call, email, or note — 6 days ago.
Next step scheduled: Aug 11, 2026
Agent — next best action for this deal
Follow up with BioNex Therapeutics
You set a follow-up with BioNex Therapeutics for 8/11/2026. Draft the recap with a concrete next step so it doesn't slip.
Recommended Services
Accelerate the upcoming NDA with CTD dossier preparation handled by former FDA/EMA reviewers, cutting prep time 30–40%.
Single-pane monitoring across FDA, EMA and 120+ agencies so the team isn't manually tracking guideline shifts during the filing window.
Activity
- In ProgressJul 16, 2026 • 4:58 PM
Had intro call. She is interested in CTD dossier support. Sending proposal next week.
Follow-up Aug 11, 2026Logged by Suren Dheen